De-Implementation of Low-value Testing in Patients Undergoing Low-Risk Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Michigan

About this trial

This trial aims to evaluate the effectiveness of a multi-level, multi-component de-implementation strategy to reduce unnecessary preoperative testing. Sixteen Michigan Value Collaborative (MVC)/Michigan Surgical Quality Collaborative (MSQC) sites in Michigan will implement several tools that have been proven to reduce unnecessary testing at a single site, including clinician education, a decision aid, audit and feedback on performance, and a pay-for-performance incentive. The researchers believe that, through the use of these strategies, there will be a significant reduction in unnecessary preoperative testing during the intervention.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Over 30% of testing rates on at least one of the three index procedures (breast lumpectomy, laparoscopic cholecystectomy, and inguinal hernia repair)

Disqualifiers

none

Trial design

Design model

Sequential

Treatments tested in this trial

  • Active de-Implementation

    Behavioral

    During active de-implementation (3 months), the local team will distribute the strategy components (i.e., clinician education, decision support, evaluation, consensus building around perioperative testing pathways, facility-specific feedback, and a pay-for-performance incentive) at the local site.

Treatment groups

16 Participants
are divided into 6 treatment groups

6

Treatment groups

See each treatment group below.

Group A: Wave 1Experimental treatment 1 intervention
Group B: Wave 2Experimental treatment 1 intervention
Group C: Wave 3Experimental treatment 1 intervention
Group D: Wave 4Experimental treatment 1 intervention
Group E: Wave 5Experimental treatment 1 intervention
Group F: Wave 6Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Number of tests within 30 days of surgery not associated with an emergency department visit

Only tests relating to three index procedures; breast lumpectomy, laparoscopic cholecystectomy, and inguinal hernia repair Data collected using MVC/MSQC database

Time frame
Within 30 days of surgery

Secondary outcomes

1

Number of unnecessary preoperative testing before low-risk surgery at MVC/MSQC sites not participating in the trial

Example related operations: laparoscopic hysterectomy, knee arthroscopy

Time frame
Up to year 2, quarter 4
2

30-day episode-based spending

Using the MVC claims data for total spending amounts

Time frame
Up to Year 2, Quarter 2
3

Number of unnecessary preoperative testing before low-risk surgery at trial sites

Example related operations: laparoscopic hysterectomy, knee arthroscopy

Time frame
Up to year 2, quarter 4
4

Number of intraoperative complications

Examples: myocardial infarction, stroke

Time frame
Up to year 2, quarter 4

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Michigan

Lead sponsor

Agency for Healthcare Research and Quality (AHRQ)

Collaborator

Blue Cross Blue Shield of Michigan Foundation

Collaborator